dc.contributor.author | Copur, Mazlum | |
dc.contributor.author | Copur, Sidar | |
dc.date.accessioned | 2023-01-30T11:36:49Z | |
dc.date.available | 2023-01-30T11:36:49Z | |
dc.date.issued | 2019 | en_US |
dc.identifier.citation | Copur, M., & Copur, S. (2019). Emergence of tic disorder in a pediatric patient associated with risperidone and aripiprazole treatment. ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 20(6), 671-671. | en_US |
dc.identifier.issn | 1302-6631 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12294/3197 | |
dc.description.abstract | An atypical anti-psychotic drug, risperidone, used in
the treatment of schizophrenia, bipolar mania and
irritability associated with autism spectrum disorder
works primarily by inhibiting serotonergic (5-HT2A)
and dopaminergic (D2) systems.
1 Common adverse
effects include cerebrovascular events, tardive dyskinesia, neuroleptic malignant syndrome, orthostatic
hypotension, cytopenia, Parkinson-like symptoms,
motor impairment, seizures, metabolic alterations and
hyperprolactinemia. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | CUMHURIYET UNIV TIP FAK PSIKIYATRI ANABILIM DALI | en_US |
dc.relation.ispartof | ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Emergence of tic disorder in a pediatric patient associated with risperidone and aripiprazole treatment | en_US |
dc.type | letter | en_US |
dc.department | Rektörlük | en_US |
dc.authorid | 0000-0001-9218-0296 | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 671 | en_US |
dc.identifier.endpage | 671 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.institutionauthor | Copur, Mazlum | |
dc.authorwosid | DWH-8942-2022 | en_US |
dc.authorscopusid | 8346360900 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.identifier.wos | WOS:000490862500016 | en_US |
dc.identifier.scopus | 2-s2.0-85090632098 | en_US |